Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 4:31 pm Unchanged | 2023-02-01 | 13D | Solid Biosciences Inc. SLDB | Perceptive Advisors LLC | 3,501,265 17.900% | 0 (Unchanged) | Filing History |
| 2023-02-02 5:01 pm Purchase | 2023-02-01 | 13D | Athenex, Inc. ATNX | Perceptive Advisors LLC | 776,623 9.900% | 100,000 (+14.78%) | Filing History |
| 2023-01-13 5:07 pm Unchanged | 2023-01-10 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,486,992 36.900% | 0 (Unchanged) | Filing History |
| 2022-12-21 4:30 pm Purchase | 2022-12-19 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 2,487,802 9.900% | 2,487,802 (New Position) | Filing History |
| 2022-12-06 4:30 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | Perceptive Advisors LLC | 3,501,265 17.900% | 2,603,762 (+290.11%) | Filing History |
| 2022-11-18 4:31 pm Purchase | 2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Perceptive Advisors LLC | 3,007,858 14.400% | 3,007,858 (New Position) | Filing History |
| 2022-11-03 4:33 pm Sale | 2022-10-31 | 13G | Quotient Limited QTNT | Perceptive Advisors LLC | 0 0.000% | -405,020 (Position Closed) | Filing History |
| 2022-09-23 4:31 pm Purchase | 2022-09-16 | 13G | Relmada Therapeutics, Inc. RLMD | Perceptive Advisors LLC | 2,099,952 7.000% | 2,099,952 (New Position) | Filing History |
| 2022-09-02 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | Perceptive Advisors LLC | 897,503 11.900% | 3,333 (+0.37%) | Filing History |
| 2022-08-09 09:15 am Sale | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,486,992 36.900% | -309,092 (-17.21%) | Filing History |
| 2022-07-18 8:59 pm Purchase | 2022-07-05 | 13G | Inhibrx Biosciences, Inc. INBX | Perceptive Advisors LLC | 1,968,744 5.000% | 1,968,744 (New Position) | Filing History |
| 2022-07-01 4:45 pm Purchase | 2022-06-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 481,115 12.800% | 138,523 (+40.43%) | Filing History |
| 2022-06-21 09:07 am Purchase | 2022-06-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Perceptive Advisors LLC | 2,971,413 5.100% | 2,971,413 (New Position) | Filing History |
| 2022-04-25 7:02 pm Unchanged | 2022-04-25 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 0 (Unchanged) | Filing History |
| 2022-04-20 9:17 pm Purchase | 2022-04-18 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 1,674,151 (+45.75%) | Filing History |
| 2022-04-14 5:10 pm Purchase | 2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 182,935 24.800% | 118,483 (+183.83%) | Filing History |
| 2022-03-02 4:16 pm Sale | 2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 27,356,043 9.700% | -400 (-0.00%) | Filing History |
| 2022-03-02 3:38 pm Purchase | 2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 27,356,443 9.700% | 797,000 (+3.00%) | Filing History |
| 2022-02-22 5:19 pm Unchanged | 2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 26,559,443 9.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 9:12 pm Purchase | 2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 4,849,912 9.800% | 672,191 (+16.09%) | Filing History |